Lifirafenib maleate

Overview

Lifirafenib (BGB-283) maleate is a novel and potent Raf Kinase and EGFR inhibitor with IC 50 values of 23 and 29 nM for recombinant BRaf V600E and EGFR , respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Others | Products > Signaling Pathways > EGFR | Products > Signaling Pathways > Raf

Product Information

• Catalog No.: HY-18957B
• CAS No.: 1854985-74-2
• Molecular Formula: C25H17F3N4O3.3/2C4H4O4
• Molecular Weight: 652.53
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source